As a a scientist and an experienced biotech entrepreneur Dr. Dinko Valerio is founder and former CEO of Crucell, and one of the founders of its spinout, Galapagos Genomics. He was founder and former general partner of Aescap Venture, a life sciences venture capital firm. Adding to his corporate experience, Dr. Dinko Valerio was also a professor of gene therapy at the University of Leiden. He received his Masters degree in Biology from the University of Amsterdam and completed his Ph.D. in Molecular Genetics with Honors at the University of Leiden. Dr. Dinko Valerio was a visiting scientific specialist at Genentech Inc., San Francisco and a postdoctoral fellow at the Salk Institute, San Diego. He is an author on more than 100 articles in peer-reviewed journals and an inventor on 11 patent-families.